Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 3, 2016
November 15, 2022
12e2fbc0-e56f-4be2-8fa3-278d7a366326
Related Documents
Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers
Guidance DocumentOctober 22, 2025Center for Drug Evaluation and Research
M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry
Guidance DocumentOctober 3, 2017Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Guidance DocumentJuly 19, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox